Parabilis Medicines
Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.
About Parabilis Medicines
Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced a novel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.
Company Facts
- Headquarters
- Cambridge
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- late_stage_venture
- Total Funding
- $835,271,035
- Last Funding Type
- series_f
- Last Funding Date
- 2026-01-08
- Website
- parabilismed.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical, Pharmaceutical, Precision Medicine
Social Links
Canonical: https://fsome.com/organization/parabilis-medicines-2164 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.